(Archived) Senior Associate Director/Associate Director, US Product CMC Regulatory Affairs (Remote)

Description

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.

The Associate Director, US Product CMC Regulatory Affairs is responsible for the coordination and execution of regulatory activities required of an IND/NDA/BLA Holder for compliance to FDA requirements for BI's investigational and US market product portfolio. These responsibilities include management of CMC and product labeling changes as well as the preparation and submission of original and/or supplemental applications and post marketing reports per US FDA regulations.

The Associate Director, US Product CMC Regulatory Affairs acts as primary internal contact for all US regulatory relevant topics. Additionally, with support and guidance from the Sr. Associate Director / Director, acts as liaison to FDA for routine marketed product interactions. It is expected that the Associate Director position can support projects of increasing regulatory complexity and/or business impact.

Duties & Responsibilities

• Supervises, coaches, and develops the skills of CMC RA Specialists.

CMC Lifecycle Management:

• Effects timely and appropriate regulatory change management of CMC changes, including those of increasing complexity and/or business impact, in accord with the Corporate Change Management Procedures.
• Supports Local Change Review Committees at manufacturing sites in their evaluation of the impact of a CMC change.
• Assesses the regulatory impact of the proposed CMC changes on the US NDA/BLA. Define CMC documents needed to support the change.
• With supervisory support, evaluates submission documentation for gaps in data/information and identifies risks/mitigation strategies as appropriate.
• Contributes to maintenance of BI’s databases on post approval requirements (e.g., Variations database) for US requirements.

Labeling:

• As member of Product Labeling Review Team (PLRT) and in collaboration with US RA Labeling Content, provide regulatory support during Annual, CCDS, or ad-hoc product labeling reviews.
• Collaborates with US RA Labeling Content and Labeling Operations to facilitate submission of labeling supplements and implementation of changes to labeling.
• Provides input on Country-of-Origin markings as needed.

IND/NDA/BLA Submissions:

• Reviews and approves regulatory documents for submission, constructs in eCTD format, and file, original IND/NDA/BLA (or) IND Amendments (or) supplemental sNDA/sBLA submissions for CMC and/or labeling and supports their approval by FDA, including those of increased complexity and/or business impact.
• Freedom to act in addressing standard FDA comments with minimal potential impact on submission timelines or approvals and leverages line management support to address more complex or unusual questions.
• With modest oversight, manages the negotiation of labeling changes with FDA as needed.

NDA/BLA Post Marketing Reports:

• Manages the preparation and final content and submission of the NDA/BLA Annual Report, each year within 60 days of the anniversary date of U.S. approval of the application.
• Periodic Adverse Experience Reports (e.g., PADER, PBRER); Manages the preparation and submission and contributes to content.
• Biologic Distribution Reports: Manages the preparation and submission of reports providing information about the quantity of the product distributed under the BLA.
• NDA – Field Alert Report/Biological Product Deviation Report: Contributes to assessment of potential quality defects, technical product complaints and/or patient complaints and participates (with support from line management) in internal committees for decision making on FARs/BPDRs, potential market impact and communication to FDA as appropriate.

FDA Liaison:

• Liaises with FDA in written communication and participate in FDA meetings on regulatory issues.
• In collaboration with more experienced CMC RA personnel, prepares cross-functional teams for FDA interactions on regulatory issues and provides guidance on preparation of briefing packages.

Requirements

• Required: Minimum BS/BA. Chemistry, Biology, Pharmaceutical Science or relevant field of study preferred. An advanced degree is desirable.
• With BS/BA: Min six (6) years’ work experience in pharma industry, FDA, or equivalent.
• With M.S.: Min four (4) years’ work experience in pharma industry, FDA, or equivalent.
• With Ph.D.: Min two (2) years’ work experience in pharma industry, FDA, or equivalent.
• Excellent communication (verbal, written and presentation) skills.
• Excellent skills in planning, organizing, and problem-solving with developing decision-making skills.
• Excellent interpersonal skills.
• Willing to travel, both domestic and internationally up to ten percent of the time.
• Computer and information technology literacy.
• Critical thinker with ability to self-manage workload.
• Ability to work well under pressure, influence without decision-making authority, work in a team environment, flexibility to adapt in a changing environment.
• Detail oriented but also able to see “big picture”.

Eligibility Requirements:

• Must be legally authorized to work in the United States without restriction.
• Must be willing to take a drug test and post-offer physical (if required).
• Must be 18 years of age or older.

Desired Skills, Experience and Abilities

Additional Duties & Responsibilities:

DMFs:

• Acts as US Agent for BI’s Type II DMFs incorporated into investigational and marketed products; prepares and submits Type II DMF amendments and the DMF Annual Report on behalf of the DMF Holder.

CMC Development:

• Provides US CMC regulatory guidance to international development CMC sub teams in accordance with the CMC Functional Summary Document.
• With minimal supervision, delivers US regulatory strategies and support for development programs of increasing complexity and leverage knowledge, and experience to provide risk based regulatory solutions meeting regulatory expectations and development objectives from SOD through NDA/BLA registration.
• Contributes to the maintenance of BI's databases for US CMC development requirements.

Compensation

This position offers a base salary typically between $111,000 and $232,000. The position may be eligible for a role specific variable or performance based bonus and or other compensation elements.  For an overview of our benefits please click here.